Clinical TrialsSearch results
Number of results: 527
Recruiting
- A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma.
- Unresectable Pleural Mesothelioma
- Hibi Kazushige
- 2023-11-11
Recruiting
- A randomised controlled trial evaluating the efficacy of an open-ended urinary catheter for catheter-related bladder discomfort
- Non muscle invasive bladder cancer, renal cell carcinoma, upper truct urothelial carcinoma
- Hinata Nobuyuki
- 2024-07-24
Recruiting
- A Randomized Controlled Trial of Cervical Electrical Stimulation for Parkinson's Disease
- Parkinson's Disease
- Maruyama Hirofumi
- 2024-07-29
Recruiting
- A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)
- COPD
- Ageishi Yuji
- 2024-03-27
Recruiting
- A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
- early AD
- Nakagawa Masaki
- 2024-10-10
Recruiting
- A study of the efficacy of preoperative marking for liver tumors
- Liver tumor
- Ohdan Hideki
- 2023-01-25
Recruiting
- A study on the efficacy and safety of ED1000 in post-prostatectomy patients
- Prostate cancer
- Hinata Nobuyuki
- 2023-11-09
Recruiting
- A study to determine the optimal dose of folic acid supplementation in patients with rheumatic diseases on methotrexate treatment
- Patients on methotrexate therapy regularly take folic acid supplementation to prevent its toxicity.
- Shintaro Hirata
- 2023-12-26
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Recruiting
- An Investigator-initiated Clinical Trial, First in Human study, wi th a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma (MIRX002-01 repeated dose study)
- Malignant pleural mesothelioma
- Morihito Okada
- 2022-05-11